← Scroll for more →
Annovis Bio, Inc. (ANVS)
Pharmaceutical Preparations
Latest Price
$1.21
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.11
P/B Ratio
10.77
Institutional Ownership
27.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Empery Asset Management, LP | 2.40M | $4.0M | 5.64% | -- | 2026-06-30 |
| Marshall Wace, LLP | 1.84M | $3.0M | 4.32% | +654.8K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.65M | $3.0M | 3.87% | +774.9K | 2026-06-30 |
| Tudor Investment Corp ET AL | 1.36M | $2.0M | 3.19% | -- | 2026-06-30 |
| Renaissance Technologies LLC | 1.00M | $1.0M | 2.35% | +654.6K | 2026-06-30 |
| Two Sigma Investments, LP | 579.6K | $1.0M | 1.36% | -- | 2026-06-30 |
| Citadel Advisors LLC | 506.5K | -- | 1.19% | +401.6K | 2026-06-30 |
| Caption Management, LLC | 474.9K | -- | 1.11% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 283.8K | -- | 0.67% | +36.3K | 2026-06-30 |
| BlackRock, Inc. | 249.9K | -- | 0.59% | +110.3K | 2026-06-30 |